For CytoCell® AML and MDS FISH Probe Kits only
Watch our brilliant Field Application Specialist, Gothami Fonseka, demonstrate the fluorescence in situ hybridization (FISH) protocol for use with OGT's CytoCell range of FDA-cleared Class II IVD FISH probe test kits for acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
Study the Package Insert (Instructions for Use, IFU) carefully before using the protocol depicted in this video. This video does not replace the content from the Package Insert.
The Package Insert can be found in the product packaging of each FISH Probe Kit and in the Product Documentation section of each FISH Probe Kit on the website.
Refer to the Package Insert for warnings, precautions, storage and handling.
The Cytocell AML/MDS range of FISH probe test kits are fluorescence in situ hybridization (FISH) tests used to detect common chromosomal rearrangements in fixed bone marrow specimens from patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). The tests are indicated for the characterization of patient specimens consistent with World Health Organization guidelines for Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th Edition) and in conjunction with other clinicopathological criteria. The assay results are to be interpreted by a qualified pathologist or cytogeneticist. The tests are not intended for use as a stand-alone diagnostic, disease screening, or as a companion diagnostic.
Refer to individual test kit Package Insert for the specific intended use and limitations.
For In Vitro Diagnostic Use. Rx only.
For sale in the US only. This product has not been licensed in accordance with Canadian law.